The relationship between attention-deficit/hyperactivity disorder (ADHD) and aggressive behaviour has been the subject of considerable research involving animals and humans (1–9). Evidence suggests that neurobiological and environmental factors contribute to different phenotypes of aggression as represented within the diagnosis of ADHD, conduct disorder (CD) and antisocial personality disorder (ASP) (10), and with oppositional defiant disorder (ODD) also being a part of the ADHD–aggression spectrum.

It is important to outline that variants of aggressive behaviour in ADHD may also be influenced by different developmental and neurobiological trajectories, in particular in view of the frequently observed co-morbidity of conduct problems with ADHD. In view of one of the most replicated findings in biological psychiatry one has to note that the serotonin deficiency hypothesis of aggression explains considerable variance (5, 6, 8, 9, 11–15). However, so far there are only few studies dealing with the serotonin deficiency hypothesis of aggression in children and adolescents, in particular with ADHD and related co-morbid conditions such as CD or ODD (16–24). With lower serotonergic responsivity assessed in childhood predicting the development of ASP in early adulthood these findings underline that this particular trajectory strongly correlated with neurobiological markers of aggression such as changed serotonergic neurotransmission, but to date there is still a lack of studies in this field as other trajectories (i.e. in terms of hormonal changes) as well as interactions between hormonal differences and altered serotonergic functioning may also be taken into consideration (25–28).

One has to note that recent research has suggested that trait-impulsivity and aggressiveness in ADHD could be potential moderators as far as serotonin-dependent aggressive behaviour in children and adolescents is concerned (1, 29–35), which also stands in relationship to the mentioned trajectory with serotonergic responsivity influencing the development from ADHD to ASP. In particular, with low impulsive patients being more susceptible to behave aggressively under a diminished central nervous serotonergic turnover one could speculate that this relationship could outline one part of a trajectory from childhood to early adulthood of serotonin-dependent aggression, and with trait-impulsivity moderating the vulnerability to develop aggressive behaviour (1) or even ASP.

In line with this, with low resting heart rate being a strong predictor of aggressive and conduct problems in children and adolescents, low impulsive children and adolescents with ADHD were shown to have a lowered heart rate under a diminished serotonergic neurotransmission (30, 36). Interestingly, low aggressive boys with ADHD also showed increased physiological reactivity along with increasing provocation of aggression (37). However, treatment with methylphenidate increased the heart rate but did not interact with the aggressive response in this study (37). Additional research indicated that boys with co-morbid ADHD/CD/ODD had higher levels of behavioural aggression along with a heightened heart rate acceleration, and that these boys were rated as angrier than all other boys compared with boys with only ADHD or ODD/CD (38). Finally, trait-aggression in terms of hostility also influenced serotonin-dependent behavioural inhibition in male children and adolescents with ADHD (34). However, a major limitation is that data on aggression in females with ADHD are scarce, underlining the need for ongoing research involving subjects of both genders and different age groups. Taken together the discussed data suggest that trait-impulsive and -aggressive characteristics along with physiological parameters (i.e. such as heart rate) could be of particular value in view of serotonin-dependent aggression from a developmental viewpoint, and could also map the pathway for research aiming to distinguish between potential endophenotypes as far as the relationship between ADHD, aggression and changed serotonergic neurotransmission is concerned.

The article by Dowson and Blackwell in the present issue clearly adds an important part of the puzzle to the ADHD–aggression relationship, in particular as such data investigating co-variations between ADHD and aggression, a scenario frequently observed in clinical settings, are currently missing (39). Moreover, DSM-IV domains of ADHD were shown to predict co-morbid impulsive aggression, with a significant overlap in view of specific features of borderline personality disorder (BPD) (39). Noteworthy is the fact that data in adults as well as in female subjects on this matter are currently lacking. In view of epidemiological differences in prevalence rates of BPD in males and females future research should take this bias into careful consideration. However, despite these limitations taken together these findings by Dowson and Blackwell have major implications for the selection of future research samples aiming to investigate aggressive behaviour in adults with ADHD (39).

In summary I believe that investigations with larger sample sizes and both genders are needed in order to further tap into the relationship between ADHD and co-varying aggressive behaviour, in particular with respect to changed serotonergic neurotransmission. This relationship could be of particular importance when it comes to potential endophenotypes in ADHD and patients with co-varying conduct problems, and also if one aims to further disentangle the frequently observed diagnostic overlap between ADHD and aggressive behaviour, in particular in view of impulsivity as a potential moderator variable. Furthermore we strongly need to focus on particular types of aggressive behaviour, i.e. such as proactive vs. reactive aggression and how these data are obtained (i.e. within a laboratory setting or within real-life interactions). Finally, as mentioned before, research aiming to involve both genders is highly mandatory as gender differences, i.e. as represented within rather indirect forms of aggression in females, are very likely to have a major impact on the data aiming to assess aggressive behaviour. These methodological issues are crucial and should be addressed in future investigations.


  1. Top of page
  2. References
  • 1
    Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F. Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion. Hum Psychopharmacol 2008;23:4351.
  • 2
    Stadler C, Zepf FD, Demisch L, Schmitt M, Landgraf M, Poustka F. Influence of rapid tryptophan depletion on laboratory-provoked aggression in children with ADHD. Neuropsychobiology 2007;56:104110.
  • 3
    Castellanos FX, Elia J, Kruesi MJ et al. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res 1994;52:305316.
  • 4
    Kruesi MJ, Rapoport JL, Hamburger S et al. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 1990;47:419426.
  • 5
    Berman ME, Tracy JI, Coccaro EF. The serotonin hypothesis of aggression revisited. Clin Psychol Rev 1997;17:651665.
  • 6
    Berman ME, Coccaro EF. Neurobiologic correlates of violence: relevance to criminal responsibility. Behav Sci Law 1998;16:303318.
  • 7
    Coccaro EF, Kavoussi RJ, Sheline YI, Berman ME, Csernansky JG. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology 1997;16:211216.
  • 8
    Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 1996;40:157164.
  • 9
    Constantino JN, Liberman M, Kincaid M. Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial. J Child Adolesc Psychopharmacol 1997;7:3144.
  • 10
    Retz W, Rosler M. The relation of ADHD and violent aggression: what can we learn from epidemiological and genetic studies? Int J Law Psychiatry 2009;doi:10.1016/j.ijlp.2009.04.006 [Epub ahead of print].
  • 11
    Mccloskey MS, Ben-Zeev D, Lee R, Berman ME, Coccaro EF. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl) 2008;203:5361.
  • 12
    Mccloskey MS, Berman ME, Echevarria DJ, Coccaro EF. Effects of acute alcohol intoxication and paroxetine on aggression in men. Alcohol Clin Exp Res 2009;33:581590.
  • 13
    Mccloskey MS, Ben-Zeev D, Lee R, Berman ME, Coccaro EF. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl) 2009;203:5361.
  • 14
    Berman ME, Mccloskey MS, Fanning JR, Schumacher JA, Coccaro EF. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 2009;doi:10.1111/j.1467-9280.2009.02355 [Epub ahead of print].
    Direct Link:
  • 15
    Berman RM, Sanacora G, Anand A et al. Monoamine depletion in unmedicated depressed subjects. Biol Psychiatry 2002;51:469473.
  • 16
    Donovan AM, Halperin JM, Newcorn JH, Sharma V. Thermal response to serotonergic challenge and aggression in attention deficit hyperactivity disorder children. J Child Adolesc Psychopharmacol 1999;9:8591.
  • 17
    Mitsis EM, Halperin JM, Newcorn JH. Serotonin and aggression in children. Curr Psychiatry Rep 2000;2:95101.
  • 18
    Schulz KP, Newcorn JH, Schmeidler J, Halperin JM. Lack of seasonal rhythms in central serotonergic function in boys with ADHD. Psychoneuroendocrinology 2002;27:463473.
  • 19
    Schulz KP, Newcorn JH, Mckay KE et al. Relationship between central serotonergic function and aggression in prepubertal boys: effect of age and attention-deficit/hyperactivity disorder. Psychiatry Res 2001;101:110.
  • 20
    Halperin JM, Kalmar JH, Schulz KP, Marks DJ, Sharma V, Newcorn JH. Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys. J Am Acad Child Adolesc Psychiatry 2006;45:833840.
  • 21
    Halperin JM, Schulz KP, Mckay KE, Sharma V, Newcorn JH. Familial correlates of central serotonin function in children with disruptive behavior disorders. Psychiatry Res 2003;119:205216.
  • 22
    Halperin JM, Newcorn JH, Kopstein I et al. Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36:13911398.
  • 23
    Halperin JM, Newcorn JH, Schwartz ST et al. Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry 1997;41:682689.
  • 24
    Halperin JM, Sharma V, Siever LJ et al. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:243248.
  • 25
    Flory JD, Newcorn JH, Miller C, Harty S, Halperin JM. Serotonergic function in children with attention-deficit hyperactivity disorder: relationship to later antisocial personality disorder. Br J Psychiatry 2007;190:410414.
  • 26
    Giammanco M, Tabacchi G, Giammanco S, Di MD, La GM. Testosterone and aggressiveness. Med Sci Monit 2005;11:RA136RA145.
  • 27
    Cotrufo P, Monteleone P, D’istria M, Fuschino A, Serino I, Maj M. Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa. Neuropsychobiology 2000;42:5861.
  • 28
    Birger M, Swartz M, Cohen D, Alesh Y, Grishpan C, Kotelr M. Aggression: the testosterone-serotonin link. Isr Med Assoc J 2003;5:653658.
  • 29
    Zepf FD, Poustka F. 5-HT functioning and aggression in children with ADHD and disruptive behavior disorders. Hum Psychopharmacol 2008;23:438.
  • 30
    Zepf FD, Holtmann M, Stadler C, Wockel L, Poustka F. Reduced serotonergic functioning changes heart rate in ADHD. J Neural Transm 2009;116:105108.
  • 31
    Zepf FD, Holtmann M, Stadler C, Magnus S, Wockel L, Poustka F. Diminished central nervous 5-HT neurotransmission and mood self-ratings in children and adolescents with ADHD: no clear effect of rapid tryptophan depletion. Hum Psychopharmacol 2009;24:8794.
  • 32
    Zepf FD. Attention deficit-hyperactivity disorder and early-onset bipolar disorder: two facets of one entity? Dialogues Clin Neurosci 2009;11:6372.
  • 33
    Zepf FD, Wockel L, Poustka F, Holtmann M. Diminished 5-HT functioning in CBCL pediatric bipolar disorder-profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance. Hum Psychopharmacol 2008;23:291299.
  • 34
    Zepf FD, Holtmann M, Stadler C et al. Diminished serotonergic functioning in hostile children with ADHD: tryptophan depletion increases behavioural inhibition. Pharmacopsychiatry 2008;41:6065.
  • 35
    Zepf FD, Wockel L, Poustka F, Holtmann M. Dietary tryptophan depletion according to body weight – a new treatment option in acute mania? Med Hypotheses 2008;72:4748.
  • 36
    Lorber MF. Psychophysiology of aggression, psychopathy, and conduct problems: a meta-analysis. Psychol Bull 2004;130:531552.
  • 37
    Pelham WE, Milich R, Cummings EM, Murphy DA, Schaughency EA, Greiner AR. Effects of background anger, provocation, and methylphenidate on emotional arousal and aggressive responding in attention-deficit hyperactivity disordered boys with and without concurrent aggressiveness. J Abnorm Child Psychol 1991;19:407426.
  • 38
    Waschbusch DA, Pelham WE, Jr, Jennings JR, Greiner AR, Tarter RE, Moss HB. Reactive aggression in boys with disruptive behavior disorders: behavior, physiology, and affect. J Abnorm Child Psychol 2002;30:641656.
  • 39
    Dowson JH, Blackwell AD. Impulsive aggression in adults with attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 2010;121:103110.